Wei Zhao

6.7k total citations · 1 hit paper
130 papers, 3.8k citations indexed

About

Wei Zhao is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Wei Zhao has authored 130 papers receiving a total of 3.8k indexed citations (citations by other indexed papers that have themselves been cited), including 66 papers in Molecular Biology, 58 papers in Oncology and 28 papers in Cancer Research. Recurrent topics in Wei Zhao's work include Cancer Cells and Metastasis (15 papers), Cancer-related molecular mechanisms research (10 papers) and MicroRNA in disease regulation (8 papers). Wei Zhao is often cited by papers focused on Cancer Cells and Metastasis (15 papers), Cancer-related molecular mechanisms research (10 papers) and MicroRNA in disease regulation (8 papers). Wei Zhao collaborates with scholars based in China, United States and Ethiopia. Wei Zhao's co-authors include Zhiqian Zhang, Gordon B. Mills, Charles M. Perou, Zhenlin Ju, Guang Peng, Timothy A. Yap, Marilyne Labrie, Lulu Wang, Yang Peng and Jianfeng Shen and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Circulation and Nature Communications.

In The Last Decade

Wei Zhao

124 papers receiving 3.7k citations

Hit Papers

PARPi Triggers the STING-Dependent Immune Response and En... 2018 2026 2020 2023 2018 100 200 300 400
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. PARPi Triggers the STING-Dependent Immune Response and Enhances the Therapeutic Efficacy of Immune Checkpoint Blockade Independent of BRCAness
    2018 427 citations Jianfeng Shen, Wei Zhao et al. Cancer Research profile →

Peers

Wei Zhao
Yadi Wu United States
Ning Ren China
Xueli Bai China
Bram De Craene Belgium
Kian‐Huat Lim United States
Limin Xia China
Bin Dong China
Zhimin He China
Adriana Eramo Italy
Yadi Wu United States
Wei Zhao
Citations per year, relative to Wei Zhao Wei Zhao (= 1×) peers Yadi Wu

Countries citing papers authored by Wei Zhao

Since Specialization
Citations

This map shows the geographic impact of Wei Zhao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wei Zhao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wei Zhao more than expected).

Fields of papers citing papers by Wei Zhao

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Wei Zhao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wei Zhao. The network helps show where Wei Zhao may publish in the future.

Co-authorship network of co-authors of Wei Zhao

This figure shows the co-authorship network connecting the top 25 collaborators of Wei Zhao. A scholar is included among the top collaborators of Wei Zhao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wei Zhao. Wei Zhao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zhao, Wei, et al.. (2025). Clinical effects of PD-1 inhibitor camrelizumab in advanced, recurrent, or metastatic cervical cancer: A meta-analysis. Letters in Drug Design & Discovery. 22(10). 100188–100188.
2.
Wu, Ye, Wenlong Zhang, Zhihua Tian, et al.. (2025). Galectin-3 in tumor-stromal cells enhances gemcitabine resistance in pancreatic adenocarcinoma by suppressing oxidative phosphorylation. Genes & Diseases. 12(5). 101702–101702. 1 indexed citations
3.
Su, Boxing, Wei Zhao, Bentao Shi, et al.. (2023). Editorial Expression of Concern: Let-7d suppresses growth, metastasis, and tumor macrophage infiltration in renal cell carcinoma by targeting COL3A1 and CCL7. Molecular Cancer. 22(1). 74–74. 2 indexed citations
4.
Yao, Xi, Yi Huang, Yunsheng Li, & Wei Zhao. (2021). [Salvianolic acid B promotes the proliferation, migration and osteogenic differentiation of human gingival mesenchymal stem cells by activating the PI3K/AKT pathway].. PubMed. 37(9). 815–820. 3 indexed citations
5.
Elkbuli, Adel, Margaret M. Byrne, Wei Zhao, et al.. (2020). Gender disparities in lung cancer survival from an enriched Florida population-based cancer registry. Annals of Medicine and Surgery. 60. 680–685. 10 indexed citations
6.
Ma, Ying, et al.. (2019). Clinical efficacy of weekly cisplatin for treatment of patients with breast cancer. Medicine. 98(37). e17114–e17114. 3 indexed citations
7.
Shen, Jianfeng, Wei Zhao, Zhenlin Ju, et al.. (2018). PARPi Triggers the STING-Dependent Immune Response and Enhances the Therapeutic Efficacy of Immune Checkpoint Blockade Independent of BRCAness. Cancer Research. 79(2). 311–319. 427 indexed citations breakdown →
8.
Yu, Jiangyong, Shuhang Wang, Wei Zhao, et al.. (2018). Mechanistic Exploration of Cancer Stem Cell Marker Voltage-Dependent Calcium Channel α2δ1 Subunit-mediated Chemotherapy Resistance in Small-Cell Lung Cancer. Clinical Cancer Research. 24(9). 2148–2158. 47 indexed citations
9.
10.
Li, Jun, Rehan Akbani, Wei Zhao, et al.. (2017). Explore, Visualize, and Analyze Functional Cancer Proteomic Data Using the Cancer Proteome Atlas. Cancer Research. 77(21). e51–e54. 83 indexed citations
11.
Zhao, Wei, et al.. (2017). [Analysis of 649 cases of stillbirth in third trimester].. PubMed. 52(12). 822–827. 1 indexed citations
12.
13.
Ning, Zhonghua, Wei Zhao, Xiaodong Li, et al.. (2015). The status of perineural invasion predicts the outcomes of postoperative radiotherapy in locally advanced esophageal squamous cell carcinoma.. PubMed Central. 8(6). 6881–90. 13 indexed citations
14.
Su, Boxing, Wei Zhao, Bentao Shi, et al.. (2014). Let-7d suppresses growth, metastasis, and tumor macrophage infiltration in renal cell carcinoma by targeting COL3A1 and CCL7. Molecular Cancer. 13(1). 206–206. 88 indexed citations
15.
Zhao, Wei, et al.. (2014). Enhancement of gefitinib-induced growth inhibition by Marsdenia tenacissima extract in non-small cell lung cancer cells expressing wild or mutant EGFR. BMC Complementary and Alternative Medicine. 14(1). 165–165. 20 indexed citations
16.
Nguyen, David H., Erik Fredlund, Wei Zhao, et al.. (2013). Murine Microenvironment Metaprofiles Associate with Human Cancer Etiology and Intrinsic Subtypes. Clinical Cancer Research. 19(6). 1353–1362. 25 indexed citations
17.
Usary, Jerry, Wei Zhao, David B. Darr, et al.. (2013). Predicting Drug Responsiveness in Human Cancers Using Genetically Engineered Mice. Clinical Cancer Research. 19(17). 4889–4899. 40 indexed citations
18.
Du, Jing, Wei Zhao, Yusheng Wang, & Yan Cai. (2012). Lentivirus Vector-Mediated Knockdown of Erythropoietin-Producing Hepatocellular Carcinoma Receptors B4 Inhibits Laser-Induced Choroidal Neovascularization. Journal of Ocular Pharmacology and Therapeutics. 29(1). 14–22. 5 indexed citations
19.
20.
Guo, Xin, Yulin Li, He Xu, et al.. (2006). Human Bone Marrow Mesenchymal Stem Cells Differentiate Toward Endothelial Lineage in vitro. Zhongguo bingli shengli zazhi. 22(8). 1586–1590. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Yadi Wu Breakdown of academic impact, for papers by Ning Ren Breakdown of academic impact, for papers by Xueli Bai Breakdown of academic impact, for papers by Bram De Craene Breakdown of academic impact, for papers by Kian‐Huat Lim Breakdown of academic impact, for papers by Limin Xia Breakdown of academic impact, for papers by Bin Dong Breakdown of academic impact, for papers by Zhimin He Breakdown of academic impact, for papers by Adriana Eramo
Rankless by CCL
2026